161 related articles for article (PubMed ID: 11549427)
21. Flexible sigmoidoscopy or colonoscopy for colorectal screening: a randomized trial of performance and acceptability.
Elwood JM; Ali G; Schlup MM; McNoe B; Barbezat GO; North F; Sutton K; Parry B; Chadwick VS
Cancer Detect Prev; 1995; 19(4):337-47. PubMed ID: 7553676
[TBL] [Abstract][Full Text] [Related]
22. Influences of the absence of random assignment of bids on estimating willingness to pay using a discrete-choice question.
Takemura S; Ohida T; Sone T; Fukuda T; Takemura Y
Health Econ; 2005 Feb; 14(2):209-13. PubMed ID: 15386653
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.
Lew JB; St John DJB; Macrae FA; Emery JD; Ee HC; Jenkins MA; He E; Grogan P; Caruana M; Sarfati D; Greuter MJE; Coupé VMH; Canfell K
Int J Cancer; 2018 Jul; 143(2):269-282. PubMed ID: 29441568
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer screening among Mexican Americans at a community clinic.
Yepes-Rios M; Reimann JO; Talavera AC; Ruiz de Esparza A; Talavera GA
Am J Prev Med; 2006 Mar; 30(3):204-10. PubMed ID: 16476635
[TBL] [Abstract][Full Text] [Related]
25. A cost analysis of screening methodology for family members of colorectal cancer patients.
Rozen P; Ron E
Am J Gastroenterol; 1989 Dec; 84(12):1548-51. PubMed ID: 2512809
[TBL] [Abstract][Full Text] [Related]
26. Estimates of costs and effects of screening for colorectal cancer in the United States.
Byers T; Gorsky R
Cancer; 1992 Sep; 70(5 Suppl):1288-95. PubMed ID: 1387342
[TBL] [Abstract][Full Text] [Related]
27. Screening for colorectal cancer with flexible sigmoidoscopy by nonphysician endoscopists.
Wallace MB; Kemp JA; Meyer F; Horton K; Reffel A; Christiansen CL; Farraye FA
Am J Med; 1999 Sep; 107(3):214-8. PubMed ID: 10492313
[TBL] [Abstract][Full Text] [Related]
28. Willingness to pay for the maintenance of equity in a local ivermectin distribution scheme in Toro, Northern Nigeria.
Onwujekwe OE; Shu EN; Okonkwo PO
Public Health; 1999 Jul; 113(4):193-4. PubMed ID: 10483083
[TBL] [Abstract][Full Text] [Related]
29. Willingness to pay: a valid and reliable measure of health state preference?
O'Brien B; Viramontes JL
Med Decis Making; 1994; 14(3):289-97. PubMed ID: 7934716
[TBL] [Abstract][Full Text] [Related]
30. Prosthetic restoration in the single-tooth gap: patient preferences and analysis of the WTP index.
Augusti D; Augusti G; Re D
Clin Oral Implants Res; 2014 Nov; 25(11):1257-1264. PubMed ID: 24021020
[TBL] [Abstract][Full Text] [Related]
31. Who answers 'willingness to pay' questions?
Thomas R; Donaldson C; Torgerson D
J Health Serv Res Policy; 2000 Jan; 5(1):7-11. PubMed ID: 10787595
[TBL] [Abstract][Full Text] [Related]
32. Reappraisal of the options for colorectal cancer screening in England.
Whyte S; Chilcott J; Halloran S
Colorectal Dis; 2012 Sep; 14(9):e547-61. PubMed ID: 22390210
[TBL] [Abstract][Full Text] [Related]
33. Methods and Economic Considerations: Group 1 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003. fulfillment corporate.
Steele RJ; Gnauck R; Hrcka R; Kronborg O; Kuntz C; Moayyedi P; O'Morain C; Spicák J; Vainio H
Endoscopy; 2004 Apr; 36(4):349-53. PubMed ID: 15057689
[No Abstract] [Full Text] [Related]
34. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy.
Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G
Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874
[TBL] [Abstract][Full Text] [Related]
35. Willingness-to-pay for community-based insurance in Burkina Faso.
Dong H; Kouyate B; Cairns J; Mugisha F; Sauerborn R
Health Econ; 2003 Oct; 12(10):849-62. PubMed ID: 14508869
[TBL] [Abstract][Full Text] [Related]
36. Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom.
Whynes DK; Frew EJ; Edwards R; Atkin WS
Int J Technol Assess Health Care; 2003; 19(2):384-95. PubMed ID: 12862195
[TBL] [Abstract][Full Text] [Related]
37. Willingness to pay for colorectal cancer screening in Guangzhou.
Zhou Q; Li Y; Liu HZ; Liang YR; Lin GZ
World J Gastroenterol; 2018 Nov; 24(41):4708-4715. PubMed ID: 30416318
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer screening, 1997-1999: role of income, insurance and policy.
Adams EK; Thorpe KE; Becker ER; Joski PJ; Flome J
Prev Med; 2004 May; 38(5):551-7. PubMed ID: 15066357
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness analysis of colorectal cancer screening methods in Iran.
Allameh Z; Davari M; Emami MH
Arch Iran Med; 2011 Mar; 14(2):110-4. PubMed ID: 21361717
[TBL] [Abstract][Full Text] [Related]
40. The Effect of a Health Education Intervention on Jordanian Participants' Colorectal Cancer Knowledge, Health Perceptions, and Screening Practices.
Abuadas FH; Petro-Nustas WJ; Abuadas MH
Cancer Nurs; 2018; 41(3):226-237. PubMed ID: 28252461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
